Although increased expression of MT1-MMP in prostate adenocarcinoma has already been reported our study showed overexpression of both LIMK1 and MT1-MMP in the same tumor samples, which supports our in vitro studies and shows an association between LIMK1 and MT1-MMP expressions in clinical samples. The gene discussed is LIMK1; the disease is prostate adenocarcinoma.